Literature DB >> 29499146

Organoid Models of Cancer Explode with Possibilities.

Senthil K Muthuswamy1.   

Abstract

Organoids have tremendous promise for modeling human cancers and revealing new biological insights. Sachs et al. (2018), Seino et al. (2018) (in this issue of Cell Stem Cell), and Broutier et al. (2017) derive cancer organoids from breast, pancreas, and liver, respectively, not only reporting new methodologies but also showing their utility for translational and clinical cancer research.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29499146     DOI: 10.1016/j.stem.2018.02.010

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  9 in total

Review 1.  Organoid technology and applications in cancer research.

Authors:  Hanxiao Xu; Xiaodong Lyu; Ming Yi; Weiheng Zhao; Yongping Song; Kongming Wu
Journal:  J Hematol Oncol       Date:  2018-09-15       Impact factor: 17.388

Review 2.  Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine.

Authors:  Hanxiao Xu; Ying Jiao; Shuang Qin; Weiheng Zhao; Qian Chu; Kongming Wu
Journal:  Exp Hematol Oncol       Date:  2018-12-05

Review 3.  Bioinformatics and computational approaches for analyzing patient-derived disease models in cancer research.

Authors:  Deena M A Gendoo
Journal:  Comput Struct Biotechnol J       Date:  2020-02-05       Impact factor: 7.271

Review 4.  Characterization of Organoid Cultures to Study the Effects of Pregnancy Hormones on the Epigenome and Transcriptional Output of Mammary Epithelial Cells.

Authors:  Michael F Ciccone; Marygrace C Trousdell; Camila O Dos Santos
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-11-01       Impact factor: 2.673

Review 5.  Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.

Authors:  Jingjing Qu; Farhin Shaheed Kalyani; Li Liu; Tianli Cheng; Lijun Chen
Journal:  Cancer Commun (Lond)       Date:  2021-10-29

Review 6.  Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?

Authors:  Yanyun Gao; Marianna Kruithof-de Julio; Ren-Wang Peng; Patrick Dorn
Journal:  Cancers (Basel)       Date:  2022-08-02       Impact factor: 6.575

Review 7.  The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers.

Authors:  Ya-Ya Yu; Yan-Juan Zhu; Zhen-Zhen Xiao; Ya-Dong Chen; Xue-Song Chang; Yi-Hong Liu; Qing Tang; Hai-Bo Zhang
Journal:  Biomark Res       Date:  2022-10-08

8.  A thioredoxin reductase inhibitor ethaselen induces growth inhibition and apoptosis in gastric cancer.

Authors:  Wang Wu; Zhiying Yang; Xing Xiao; Tailai An; Bo Li; Jun Ouyang; Huafu Li; Chunming Wang; Yawei Zhang; Haiyong Zhang; Yulong He; Changhua Zhang
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

Review 9.  Future Match Making: When Pediatric Oncology Meets Organoid Technology.

Authors:  Virginie Barbet; Laura Broutier
Journal:  Front Cell Dev Biol       Date:  2021-07-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.